(Q51068972)

English

Clinical Significance of Androgen Receptor Splice Variant-7 mRNA Detection in Circulating Tumor Cells of Men With Metastatic Castration-Resistant Prostate Cancer Treated With First- and Second-Line Abiraterone and Enzalutamide.

scientific article published on 6 April 2017

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

14 July 2018

http://europepmc.org/abstract/PMC/5493048

Clinical Significance of Androgen Receptor Splice Variant-7 mRNA Detection in Circulating Tumor Cells of Men With Metastatic Castration-Resistant Prostate Cancer Treated With First- and Second-Line Abiraterone and Enzalutamide. (English)

1 reference

Europe PubMed Central

14 July 2018

http://europepmc.org/abstract/PMC/5493048

prostate cancer

1 reference

based on heuristic

inferred from title

Kenneth J. Pienta

11

object named as

Kenneth J Pienta

1 reference

Europe PubMed Central

14 July 2018

http://europepmc.org/abstract/PMC/5493048

author name string

Emmanuel S Antonarakis

1

1 reference

Europe PubMed Central

14 July 2018

http://europepmc.org/abstract/PMC/5493048

Changxue Lu

2

1 reference

Europe PubMed Central

14 July 2018

http://europepmc.org/abstract/PMC/5493048

Brandon Luber

3

1 reference

Europe PubMed Central

14 July 2018

http://europepmc.org/abstract/PMC/5493048

Hao Wang

4

1 reference

Europe PubMed Central

14 July 2018

http://europepmc.org/abstract/PMC/5493048

Yan Chen

5

1 reference

Europe PubMed Central

14 July 2018

http://europepmc.org/abstract/PMC/5493048

Yezi Zhu

6

1 reference

Europe PubMed Central

14 July 2018

http://europepmc.org/abstract/PMC/5493048

John L Silberstein

7

1 reference

Europe PubMed Central

14 July 2018

http://europepmc.org/abstract/PMC/5493048

Maritza N Taylor

8

1 reference

Europe PubMed Central

14 July 2018

http://europepmc.org/abstract/PMC/5493048

Benjamin L Maughan

9

1 reference

Europe PubMed Central

14 July 2018

http://europepmc.org/abstract/PMC/5493048

Samuel R Denmeade

10

1 reference

Europe PubMed Central

14 July 2018

http://europepmc.org/abstract/PMC/5493048

Channing J Paller

12

1 reference

Europe PubMed Central

14 July 2018

http://europepmc.org/abstract/PMC/5493048

Michael A Carducci

13

1 reference

Europe PubMed Central

14 July 2018

http://europepmc.org/abstract/PMC/5493048

Mario A Eisenberger

14

1 reference

Europe PubMed Central

14 July 2018

http://europepmc.org/abstract/PMC/5493048

Jun Luo

15

1 reference

Europe PubMed Central

14 July 2018

http://europepmc.org/abstract/PMC/5493048

language of work or name

0 references

publication date

6 April 2017

1 reference

Europe PubMed Central

14 July 2018

http://europepmc.org/abstract/PMC/5493048

Journal of Clinical Oncology

1 reference

Europe PubMed Central

14 July 2018

http://europepmc.org/abstract/PMC/5493048

35

1 reference

Europe PubMed Central

14 July 2018

http://europepmc.org/abstract/PMC/5493048

19

1 reference

Europe PubMed Central

14 July 2018

http://europepmc.org/abstract/PMC/5493048

2149-2156

1 reference

Europe PubMed Central

14 July 2018

http://europepmc.org/abstract/PMC/5493048

Association of AR-V7 on Circulating Tumor Cells as a Treatment-Specific Biomarker With Outcomes and Survival in Castration-Resistant Prostate Cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5493048

15 July 2018

Androgen receptor variant-driven prostate cancer: clinical implications and therapeutic targeting

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5493048

15 July 2018

Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5493048

15 July 2018

RNA-Seq of single prostate CTCs implicates noncanonical Wnt signaling in antiandrogen resistance.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5493048

15 July 2018

Androgen Receptor Splice Variant 7 and Efficacy of Taxane Chemotherapy in Patients With Metastatic Castration-Resistant Prostate Cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5493048

15 July 2018

AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5493048

15 July 2018

Increased survival with enzalutamide in prostate cancer after chemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5493048

15 July 2018

Abiraterone and increased survival in metastatic prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5493048

15 July 2018

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5493048

15 July 2018

Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical Trials Working Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5493048

15 July 2018

Expression of AR-V7 in Circulating Tumour Cells Does Not Preclude Response to Next Generation Androgen Deprivation Therapy in Patients with Castration Resistant Prostate Cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5493048

14 August 2018

Efficacy of Cabazitaxel in Castration-resistant Prostate Cancer Is Independent of the Presence of AR-V7 in Circulating Tumor Cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5493048

14 August 2018

Identifiers

10.1200/JCO.2016.70.1961

1 reference

Europe PubMed Central

14 July 2018

http://europepmc.org/abstract/PMC/5493048

1 reference

Europe PubMed Central

14 July 2018

http://europepmc.org/abstract/PMC/5493048

1 reference

Europe PubMed Central

14 July 2018

http://europepmc.org/abstract/PMC/5493048

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51068972&oldid=1521663433"